Sign in

CIK 0001101026

  • Non-accelerated filer
  • Smaller reporting company

Zivo Bioscience, Inc.

Sign in to watch
Ticker
ZIVO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870699977
Phone
+1 248-452-9866
Business address
21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
Former names
HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 197,000 shares at an average $0.10 ($19,510)
  3. 4 Open-market buy Director bought 20,000 shares at $0.08 ($1,600)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 93,000 shares at an average $0.07 ($6,920)
  7. 4 Open-market buy Director bought 50,000 shares at $0.07 ($3,500)
  8. 4 Open-market buy Director bought 50,000 shares at $0.08 ($4,000)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Director bought 20,000 shares at $0.07 ($1,350)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Director bought 84,000 shares at an average $0.07 ($5,778)
  13. 4 Open-market buy Director bought 114,000 shares at an average $0.07 ($7,467)
  14. 4 Open-market buy 10% owner bought 107,064 shares at $0.08 ($8,565)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy 10% owner bought 299,400 shares at $0.13 ($39,850)
  17. 4 Open-market buy Director bought 50,000 shares at $0.08 ($4,245)
  18. 4 Open-market buy Director bought 39,069 shares at an average $0.09 ($3,406)
  19. 4 Open-market buy 10% owner bought 125,400 shares at $0.09 ($10,822)
  20. 4 Open-market buy 10% owner bought 121,000 shares at an average $0.08 ($9,471)

Page 8 of 12 · 239 filings